Examkin

Soru

Zorluk: OrtaPediatric Respiratory Disorders

An 8-year-old boy is brought to the emergency department by emergency medical services due to severe respiratory distress. The patient has a history of moderate persistent asthma but has been noncompliant with his inhaled fluticasone controller medication. Over the past 48 hours, he has experienced an escalating cough and wheezing that have not responded to his short-acting albuterol inhaler. His temperature is 37.1°C (98.8°F), pulse is 162/min, respiratory rate is 46/min, and blood pressure is 112/70 mm Hg. Pulse oximetry demonstrates an oxygen saturation of 89% on room air. Physical examination reveals an agitated child who is speaking in single words and sitting in a tripod position. He has marked supraclavicular retractions. Auscultation reveals a prolonged expiratory phase with loud, diffuse bilateral wheezing. Which of the following interventions are appropriate for the immediate management of this patient's condition? (Select 3 answers)

  1. Administration of supplemental oxygenCevap
  2. Continuous nebulization of albuterol and ipratropium bromideCevap
  3. Administration of intravenous methylprednisoloneCevap
  4. D
    Empirical treatment with intravenous ceftriaxone
  5. E
    Administration of nebulized racemic epinephrine

Cevap

The correct interventions are the administration of supplemental oxygen, continuous nebulization of albuterol and ipratropium bromide, and the administration of intravenous methylprednisolone.
This patient is presenting with severe status asthmaticus, evidenced by his hypoxia, marked retractions, inability to speak in full sentences, and lack of response to home albuterol. The standard initial management bundle for a severe asthma exacerbation in the emergency setting requires a comprehensive approach targeting multiple aspects of the pathophysiology. Supplemental oxygen is immediately necessary to correct his hypoxemia (SpO2 < 90%). Continuous nebulization of short-acting beta-agonists (albuterol) combined with an anticholinergic agent (ipratropium bromide) provides rapid and synergistic relief of acute smooth muscle bronchospasm. Simultaneously, systemic corticosteroids (such as intravenous methylprednisolone) must be administered to address the underlying severe airway inflammation, decrease mucus production, and prevent subsequent relapses. Together, these three interventions form the critical foundation of status asthmaticus management.

Adım Adım Çözüm

1
Identify the patient's acute clinical condition.
The patient is experiencing acute status asthmaticus, characterized by severe respiratory distress, hypoxemia, tachycardia, tachypnea, and diffuse bilateral wheezing unresponsive to initial home albuterol therapy.
Recognizing the severity of the asthma exacerbation dictates the aggressiveness of the initial treatment bundle.
2
Determine the necessary pharmacological and supportive interventions.
A multi-pronged approach is required: addressing hypoxemia, reversing bronchospasm, and reducing airway inflammation.
Asthma pathophysiology in an acute exacerbation involves smooth muscle constriction, airway edema, and mucus plugging.
3
Select the appropriate therapies for each pathophysiological target.
Supplemental oxygen addresses hypoxemia. Nebulized albuterol and ipratropium address acute bronchospasm. Intravenous methylprednisolone addresses the underlying airway inflammation.
This combination represents the standard evidence-based bundle for severe pediatric asthma exacerbations in the emergency department setting.

Anahtar Kavram

The initial management bundle for severe acute status asthmaticus requires simultaneous administration of supplemental oxygen, continuous inhaled short-acting bronchodilators (albuterol and ipratropium), and systemic corticosteroids.
Bu soruyu puanla

Konular

Pediatric Respiratory Disorders

Bu konudan daha fazla soru